Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/2/26 16:05 | 10/1/26 | PCVX | Health | BioPrd | Biological Products, (No Diag | Wassil Jim | CA | O | EVP,Chie | 4 | S.dm | -625 | 58.45 | 0 | -11 | 158 | D | |||||||||||||||
8/5/26 19:01 | 8/5/26 | PCVX | Health | BioPrd | Biological Products, (No Diag | Dhaliwal Harpreet S. | CA | O | Chief Te | 1 | S.d | -935 | 55.00 | 0 | -17 | 77 | D | |||||||||||||||
8/5/26 16:58 | 8/3/26 | PCVX | Health | BioPrd | Biological Products, (No Diag | Guggenhime Andrew | CA | O | P,CFO | 1 | S.d | -539 | 53.89 | 0 | -10 | 167 | D | |||||||||||||||
7/28/26 16:10 | 7/27/26 | PCVX | Health | BioPrd | Biological Products, (No Diag | Pickering Grant | CA | DO | CEO | 1 | S.d | -1,012 | 55.63 | 0 | -18 | 586 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |